FFAR2 and graft versus host disease: In summary, our data provide mechanistic insights into microbial metabolite-mediated regulation of GVHD and identify a critical role for GPR43–ERK–NLPR3 axis in non-hematopoietic host cells such as IECs (Fig. 7) in mitigating severity of target tissue damage.